SEC Contract Filing

Filing Date: 2022-03-18

Document Content:
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>2
<FILENAME>acor-ex1010_81.htm
<DESCRIPTION>2016 INDUCEMENT PLAN
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
acor-ex1010_81.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.10</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Candara;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;">ACORDA THERAPEUTICS, INC.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Candara;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;">2016 INDUCEMENT Plan</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-family:Candara;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-family:Candara;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">Section 1.</font></p></td>
<td valign="top">
<p style="margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Candara;font-size:12pt;">Purpose</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Candara;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The purpose of the Acorda Therapeutics, Inc. 2016 Inducement Plan (the &#8220;Plan&#8221;) is to provide equity compensation to certain individuals who were not previously employees or directors of Acorda Therapeutics, Inc. (the &#8220;Company&#8221;) or its Subsidiaries in order to induce such individuals to enter into employment with the Company or its Subsidiaries, as described in Nasdaq Listing Rule 5635(c)(4). </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-family:Candara;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-family:Candara;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">Section 2.</font></p></td>
<td valign="top">
<p style="margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Candara;font-size:12pt;">Definitions</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Candara;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For purposes of the Plan, capitalized terms have the meaning provided below or, if not provided below, as provided elsewhere in the Plan:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Candara;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-style:italic;text-decoration:underline;">Award</font>&#8221; means an award that is granted under the Plan as described in Section 5.&nbsp;&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Candara;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-style:italic;text-decoration:underline;">Award Cycle</font>&#8221; means a period of consecutive fiscal years or portions thereof designated by the Committee over which Performance Awards are to be earned. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Candara;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-style:italic;text-decoration:underline;">Board</font>&#8221; means the Board of Directors of the Company.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Candara;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-style:italic;text-decoration:underline;">Change in Control</font>&#8221; have the meanings set forth in Section 10.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Candara;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-style:italic;text-decoration:underline;">Code</font>&#8221; means the Internal Revenue Code of 1986, as amended from time to time, and any successor thereto.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Candara;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none